Xencor | XNCR - Equity Capital And Reserves



Xencor reported $620.35M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
AbbVie USD 1.46B 1.86B Mar/2025
Alnylam Pharmaceuticals USD 250.59M 135.16M Jun/2025
Amgen USD 7.43B 1.22B Jun/2025
Arrowhead Research USD 522.31M 161.91M Jun/2025
AstraZeneca USD 44.72B 3.68B Jun/2025
Biogen USD 17.63B 655.3M Jun/2025
Bristol-Myers Squibb USD 17.49B 100M Jun/2025
Cytokinetics USD -737440000 471.03M Jun/2025
GlaxoSmithKline GBP 14.35B 197M Jun/2025
J&J USD 78.11B 6.62B Mar/2025
MacroGenics USD 46.62M 69.44M Jun/2025
Merck USD 49.06B 725M Jun/2025
Novartis USD 42.05B 3.6B Jun/2025
Pfizer USD 88.7B 1.64B Jun/2025
Regeneron Pharmaceuticals USD 29.94B 551.3M Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Xencor USD 620.35M 19.52M Jun/2025